January 14th, 2009
Longer lashes are no longer a lark
I’ve been meaning to give an update about my test drive of eyelash conditioner RapidLash, which I wrote about and started using at the end of the summer. Today seems absolutely fitting as the New York Times reports the FDA approval of Allergan’s prescription-only eyelash-growing serum, called Latisse. It’s based on the Botox-manufacturer’s glaucoma drug, which was found to have the beneficial side-effect of longer lashes in patients using it. (The ingredient was also controversially found in Jan Marini’s Age Intervention Lash Conditioner a while back.)
Unlike Latisse, RapidLash, a cosmetic, can’t say that it makes lashes grow, because that’s a claim reserved for drugs, which have undergone rigorous, and expensive FDA clinical trials. But that doesn’t mean RapidLash doesn’t work. At the end of September, I thought I’d found the world’s greatest mascara: My lashes were long and dark in one sweep. Turns out, my lashes had grown.
Two months later, in November, I stopped using RapidLash because my lashes were, drum roll here, long enough. (Although I didn’t get any new growth in the little bald patches I have on my lower lash line.) Since then, several facialists have commented on my long, thick lashes — definitely a new compliment. And a few weeks ago I had to trim a lash because it was nearly hitting my glasses.
RapidLash uses peptides, or amino acid chains, that now power thousands of anti-aging beauty products. Peptides have been shown in lab studies to produce collagen and elastin. But there’s been industry debate and skepticism (including my own) about whether they can do anything outside the petri dish for the skin of actual people. Do you own study, if you will, or consider buying Latisse (for twice as much), which had to prove it works in order to claim it; but my report’s in. RapidLash did something for me.












